NCT03374566View on ClinicalTrials.gov

Immunodeficiency for Severe Epstein-Barr Virus Infection

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

October 30, 2022

Study Completion Date

February 1, 2023

Conditions
Epstein-Barr Virus InfectionsImmunodeficiency
Trial Locations (1)

Unknown

Children's Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Children's Hospital of Fudan University

OTHER

NCT03374566 - Immunodeficiency for Severe Epstein-Barr Virus Infection | Biotech Hunter | Biotech Hunter